Active ingredientDesidustatCat. No. P-D053-001CAS 1616690-16-4Family · Pharmaceutical analytical standards
Desidustat
An oral inhibitor of the prolyl hydroxylase (PHD) enzymes, studied in India and Australia: it boosts the body's own erythropoietin production against anaemia of chronic kidney disease, cleared in India between 2021 and 2022 and in China in 2026. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It "tricks" the kidney by mimicking a lack of oxygen: it exploits the HIF factors, which cells use to adapt to the oxygen available, a mechanism explained by Kaelin, Ratcliffe and Semenza, awarded the 2019 Nobel Prize in Medicine.
Go to the active ingredient →Active ingredientDesidustatCat. No. P-D053-001CAS 1616690-16-4
Isotopically labelledDesidustat Impurity 1-d7Cat. No. P-D053-002
Isotopically labelledDesidustat-d4Cat. No. P-D053-003
ImpurityDesidustat Impurity 1Cat. No. P-D053-004CAS 931398-72-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.